Alembic Pharmaceuticals Ltd. Fundamental & Technical Research, Share Price Today

NSE : APLLTD
NIFTY : Nifty 500
NIFTY SECTOR : Nifty MidSmall Healthcare

About Company

Alembic Pharmaceuticals Limited is involved in manufacturing and marketing of India Formulations, International Generics, and Active Pharmaceutical Ingredients with vertical integration capabilities. Headquartered in Vadodara, Gujarat. It is the flagship company of the pioneering Alembic Group. Close to 40% of its revenues are generated from the US generics business, while 18% of its business comes from third-party API sales. The company’s capabilities also extend to making oral solid & injectables in Oncology, general & complex injectables and ophthalmology. The company’s manufacturing facility in Sikkim is dedicated for manufacturing its India Formulations.

Market Cap. ₹16,609 Cr.

52 Week - High/Low ₹1,304/725

P/E Ratio 26.38

P/B Ratio 3.38

Enterprise Value ₹16,666 Cr.

ROE % 14.3

RSI Value 92.88

EMA 50 893.47

EMA 200 895.97

Net Profit 666 Cr.

Net Profit 3year growth -39.22 Cr.

Net Profit 3 year (back) 1,097 Cr.

Debt to Equity 0.09 %

EPS Growth TTM 5.78 %

Current Ratio 2.21 %

100 Day SMA 956 Rs.

200 Day SMA 1,031 Rs.

21 Day SMA 870 Rs.

50 Day SMA 859 Rs.

Book Value 250 Rs.

EV/EBITDA Ratio 16

QoQ EPS Growth -48 %

QoQ Operating Profit Growth -34 %

QoQ Sales Growth -11 %

Sales Latest Quarter 1,406 Cr.

YoY Sales Growth -11 %

Market Cap. ₹16,609 Cr.

52 Week - High/Low ₹1,304/725

P/E Ratio 27.51

P/B Ratio 3.45

Enterprise Value ₹16,485 Cr.

ROE % 13.4

RSI Value 92.88

EMA 50 893.47

EMA 200 895.97

Net Profit 616 Cr.

Net Profit 3year growth -0.67 Cr.

Net Profit 3 year (back) 1,146 Cr.

Debt to Equity 0.09 %

EPS Growth TTM 2.26 %

Current Ratio 2.07 %

100 Day SMA 956 Rs.

200 Day SMA 1,031 Rs.

21 Day SMA 870 Rs.

50 Day SMA 859 Rs.

Book Value 245 Rs.

EV/EBITDA Ratio 16

QoQ EPS Growth -10 %

QoQ Operating Profit Growth 3 %

QoQ Sales Growth 3 %

Sales Latest Quarter 1,693 Cr.

YoY Sales Growth 4 %

Add Parameters

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages